At the time of writing, Chromadex Corp [CDXC] stock is trading at $7.01, up 7.85%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CDXC shares have gain 22.13% over the last week, with a monthly amount glided 97.46%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Chromadex Corp [NASDAQ: CDXC] stock has seen the most recent analyst activity on August 16, 2022, when Oppenheimer downgraded its rating to a Perform. Previously, B. Riley Securities downgraded its rating to Neutral on August 11, 2022, and dropped its price target to $2.40. On March 08, 2022, ROTH Capital initiated with a Buy rating and assigned a price target of $7 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $6 on October 16, 2019. B. Riley FBR initiated its recommendation with a Buy and recommended $7 as its price target on February 14, 2019. In a note dated September 25, 2017, Ladenburg Thalmann initiated an Buy rating and provided a target price of $7 on this stock.
For the past year, the stock price of Chromadex Corp fluctuated between $1.32 and $7.08. Chromadex Corp [NASDAQ: CDXC] shares were valued at $7.01 at the most recent close of the market.
Analyzing the CDXC fundamentals
According to Chromadex Corp [NASDAQ:CDXC], the company’s sales were 91.67M for trailing twelve months, which represents an 31.21% jump. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.48 points at the first support level, and at 5.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.28, and for the 2nd resistance point, it is at 7.55.
Ratios To Look Out For
It is important to note that Chromadex Corp [NASDAQ:CDXC] has a current ratio of 2.95. As well, the Quick Ratio is 2.35, while the Cash Ratio is 1.83. Considering the valuation of this stock, the price to sales ratio is 5.61, the price to book ratio is 15.51 and price to earnings (TTM) ratio is 370.90.
Transactions by insiders
Recent insider trading involved Patrick Kristin, Director, that happened on Aug 23 ’24 when 23000.0 shares were sold. affiliate, Kristin Patrick completed a deal on Aug 23 ’24 to buy 23000.0 shares. Meanwhile, Chief Financial Officer Gerber Brianna bought 5000.0 shares on Dec 01 ’23.
